Our hypothesis is that iron accumulated in tissue, rather than in serum, may compromise cardiovascular control. Male Fischer 344 rats weighing 180 to 220 g were divided into 2 groups. In the serum iron overload group (SIO, N = 12), 20 mg elemental iron was injected ip daily for 7 days. In the tissue iron overload group (TIO, N = 19), a smaller amount of elemental iron was injected (10 mg, daily) for 5 days followed by a resting period of 7 days. Reflex heart rate responses were elicited by iv injections of either phenylephrine (0.5 to 5.0 µg/kg) or sodium nitroprusside (1.0 to 10.0 µg/kg). Baroreflex curves were determined and fitted to sigmoidal equations and the baroreflex gain coefficient was evaluated. To evaluate the role of other than a direct effect of iron on tissue, acute treatment with the iron chelator deferoxamine (20 mg/kg, iv) was performed on the TIO group and the baroreflex was reevaluated. At the end of the experiments, evaluation of iron levels in serum confirmed a pronounced overload for the SIO group (30-fold), in contrast to the TIO group (2-fold). Tissue levels of iron, however, were higher in the TIO group. The SIO protocol did not produce significant alterations in the baroreflex curve response, while the TIO protocol produced a nearly 2-fold increase in baroreflex gain (-4.34 ± 0.74 and -7.93 ± 1.08 bpm/mmHg, respectively). The TIO protocol animals treated with deferoxamine returned to sham levels of baroreflex gain (-3.7 ± 0.3 sham vs -3.6 ± 0.2 bpm/mmHg) 30 min after the injection. Our results indicate an effect of tissue iron overload on the enhancement of baroreflex sensitivity.
Introduction
The cardiovascular system has the crucial task of supplying all body cells with their metabolic needs. The complexity of this function demands efficient control mechanisms for maintaining blood pressure and flux within adequate levels in every region of the body.
An organism copes with blood fluctuations by intrinsic, neural and humoral regulatory mechanisms (1) . Of particular interest to the present research, neural regulatory mechanisms, more specifically baroreceptor feedback control, are characterized by their prompt effect (1) on a beat-to-beat time scale (2) . Several pathophysiological states are known to alter the responsiveness of the baroreflex response (2) .
Iron overload is associated with several pathophysiological states (e.g., hemoglobinopathies, hemolytic anemia, hemochromatosis) and behaviors such as smoking and excessive iron and vitamin C intake (3) . Besides the epidemiologic concern regarding dietary iron intake, iron accumulation and its relation to pathological processes is still the main focus of many heated debates (4) . Nevertheless, iron overload has undeniably been associated with cardiac and vascular dysfunctions in experimental conditions (5) (6) (7) . Experiments conducted ex vivo have shown that iron overload induces a condition of heart failure (8) in Langendorff preparations of isolated hearts. In fact, deposition of iron into the heart is emerging as an important cause of heart failure (6) . However, a detailed study of cardiovascular reflex involvement in an in vivo iron overload model has not yet been reported. Such an investigation could contribute to the use of iron overload as an animal model for studying heart failure.
Iron has been associated with the modulation of the metabolism and availability of certain chemical mediators such as nitric oxide (9) (10) (11) and carbon monoxide (12) , which are implicated in baroreflex function both peripherally and centrally (13) (14) (15) . Nitric oxide as well as oxygen-derived free radicals induced by changes in iron concentration are known to suppress baroreceptor activity particularly at high levels of arterial pressure (15) . Recent studies have demonstrated alterations in baroreflex function arising from processes that produce free radicals such as atherosclerosis, in which the baroreflex gain coefficient was shown to be decreased (16) . Although cardiac insufficiency is more closely related to the inadequacy of the heart to function as a pump, dysfunction of neural feedback mechanisms (e.g., baroreflex) has been associated with chronic heart failure. Increased sympathetic activity and plasma levels of norepinephrine, parasympathetic withdrawal and impaired baroreflex gain coefficient have been reported in chronic heart failure (17) . An increased baroreflex gain coefficient has been shown in rats with myocardial infarction (18) . Very few data are available regarding the prognostic implications of baroreflex sensitivity and heart rate (HR) variability for chronic heart failure. Nevertheless, both baroreflex sensitivity and HR variability have been shown to be markedly reduced in chronic heart failure and significantly associated with the degree of ventricular dysfunction and with further progression of the severity of the disease (17) . Thus, the impairment of baroreflex function in patients with heart failure is a well-established association. In fact, the evaluation of baroreflex sensitivity has been proposed as a diagnostic tool in such cases (19) .
Our hypothesis is that iron overload could affect baroreflex function through iron accumulation in the heart tissue. Therefore, the net effect of iron overload on the baroreflex, as demonstrated in the reports cited above, may not be related to neural control but rather to heart impairment. The present experiment was designed to compare the effect of circulating iron overload to that of iron accumulated in tissues on the baroreflex of conscious Fischer 344 rats. The effect of acute iron chelator treatment (deferoxamine) in the issue iron overload group described above was also tested.
Material and Methods

Animals and iron overload
The study was conducted on male Fischer 344 rats weighing 180 to 210 g from the main breeding stock of the Nutrition School, Federal University of Ouro Preto. Animals were kept in collective cages on a 12-h light/ dark cycle, with lights on at 7:00 am, in a controlled-temperature environment (22 ± 3ºC) . Animals were randomly divided into the following groups: serum iron overload group (SIO), tissue iron overload group (TIO) (20) , and respective controls. In the SIO protocol (N = 12), 20 mg elemental iron (0.2 ml iron dextran; Sigma, St. Louis, MO, USA) was injected ip daily for 7 days, immediately followed by baroreflex evaluation. In the TIO protocol (N = 19), less elemental iron was injected (10 mg, daily) for a shorter period of time (5 days), followed by a resting period of 7 days, after which the experiments were conducted. Sham animals (N = 31) received placebo injections (PBS) according to their respective iron-loaded groups. Seven animals from the TIO protocol, along with their respective controls (N = 7), were separated to receive deferoxamine mesylate (DFO, 20 mg/kg; Novartis AG, Basel, Switzerland), in order to determine the effect of permanent changes in baroreflex function compared to the effect of the direct action of iron. Efforts were made to avoid any unnecessary distress to the animals, in accordance with the Brazilian Society for Neuroscience and Behavior Guidelines for Animal Experimentation.
Surgical procedures and hemodynamic measurements
Under tribromoethanol anesthesia (250 mg/kg, ip; Aldrich Chemical Company, Inc., Milwaukee, WI, USA) a heat-pulled taperending polyethylene catheter (PE-10 connected to PE-50; Clay Adams, Parsippany, NJ, USA) filled with heparinized PBS (125 U/ml) was positioned inside the aorta through the left femoral artery for measurement of pulsatile arterial pressure. A second catheter was inserted into the inferior vena cava through the left femoral vein for systemic drug administration. The free endings of both catheters were tunneled subcutaneously and exteriorized through the back of the neck and connected to a swivel during the experiments. Pulsatile arterial pressure was meas-ured with a pressure transducer (model MLT0699; ADInstruments Pty Ltd., Castle Hill, NSW Australia) connected to an analog-to-digital data acquisition system (model PowerLab 400; ADInstruments). Data were sampled at 12 bits using a 200-Hz sampling rate. HR and mean arterial pressure (MAP) were derived off-line from pulsatile arterial pressure using the Chart for Windows software, version 4.1.2 (ADInstruments). HR and MAP variability was estimated by calculating the standard deviation of HR and MAP values within the recording for each animal. All experiments were performed approximately 24 h after surgery on unanesthetized freely moving rats.
Baroreflex activation
Before the experiments, rats were instrumented and allowed to adapt to the new environment for at least 30 min. A 20-to 30min recording period without any interference was allowed to elapse in order to determine baseline MAP and HR values.
A typical recording procedure consisted of continuously monitoring HR and MAP while performing intravenous bolus injections of random doses of either phenylephrine (0.5, 2.0, 3.5, and 5.0 µg/kg; Sigma) or sodium nitroprusside (1.0, 4.0, 7.0, and 10.0 µg/kg; Sigma). The methodology has been described in detail elsewhere (18) . Successive drug administration was carried out only after MAP and HR returned to baseline.
Peak values of MAP and HR in response to phenylephrine and sodium nitroprusside injections were used to evaluate the baroreflex response. The data from each experimental group were then organized in a twocolumn table with data ordered from the lowest to the highest MAP, along with the respective HR values. These data were divided into 10 mmHg pressure bins. For each pressure bin, one MAP ± SEM value was plotted against its respective HR ± SEM value. The baroreflex curve was then fitted to a sigmoidal logistic equation:
where HR min is the lower plateau, HR max is the upper plateau, b is the curvature coefficient, and MAP 50 is the MAP at the midpoint of the HR range. Individual sigmoidal functions were averaged in order to determine the mean sigmoidal fit for the group. The derivatives of individual sigmoidal baroreflex curves were calculated and averaged within an experimental group in order to determine the baroreflex gain-coefficient curve.
Acute deferoximine treatment
Experiments with the chelator DFO were carried out on 7 animals from the TIO protocol and respective controls (N = 7). The baroreflex was evaluated by intravenous bolus injection of sodium nitroprusside (1.0 and 4.0 µg/kg; Sigma) before and after iv infusion of DFO (20 mg/kg). The maximal changes in MAP and HR were evaluated and the gain coefficient was calculated by the equation:
where ∆ max MAP is the maximal change in MAP after injection of sodium nitroprusside and ∆ max HR is the maximal change in HR due to the changes in MAP caused by the pharmacological maneuver.
Determination of iron status
At the end of the experiments, a blood sample was taken through the arterial cannula and centrifuged and serum separated. Serum iron concentrations were determined in non-hemolyzed serum samples by spectrophotometric analysis using commercially available kits (# 38; Labtest, Belo Horizonte, MG, Brazil). Immediately after blood sampling, the animals were sacrificed with ethyl ether and perfused with saline and formaldehyde. The liver and spleen were removed and weighed and liver and spleen samples were homogenized in HNO 3 at 120ºC. After evaporation of the acid, the dry residue was resuspended in 50% hydrochloric acid (v/v) and quantified by colorimetric analysis using orthophenanthroline (21) .
Statistical analysis
Data are reported as means ± SEM. The baroreflex curves were analyzed by one-way analysis of variance (ANOVA) for repeated measures. The unpaired Student t-test was used to determine statistically significant differences between the SIO and TIO experimental groups. The paired Student t-test was used to determine the statistically significant differences in the TIO baroreflex gain coefficient before and after DFO treatment. The level of significance was set at P < 0.05 in all analyses.
Results
Iron status and baseline cardiovascular parameters
The iron status of the animals treated with iron dextran confirmed our expectations regarding the effect of serum and tissue iron overload on the baroreflex response (Table 1) , i.e., the SIO group presented very high serum levels of iron (29-fold) compared to the modest increase observed in the TIO group (1.8-fold). On the other hand, tissue accumulation (e.g., spleen and liver) of iron was much more evident in the TIO group, even though less iron was injected when compared to the SIO animals.
Both iron-treated groups showed a slight, but significant, bradycardia compared to the sham group (SIO protocol: 341 ± 4 vs 373 ± 5
bpm; TIO protocol: 354 ± 7 vs 373 ± 5 bpm). However, baseline MAP values were not significantly different between groups (Figure 1) .
A slight decrease in pulse pressure was observed in TIO rats compared to sham rats (37.9 ± 0.92 vs 40.5 ± 0.85 mmHg, P = 0.034; data not shown). SIO rats did not present alterations in pulse pressure when compared with sham rats (37.0 ± 0.89 vs 38.8 ± 0.94 mmHg, P = 0.186; data not shown). The HR time domain variability was decreased in both iron-loaded groups compared to the sham group (SIO protocol: 14 ± 1 vs 19 ± 2 bpm; TIO protocol: 13 ± 1 vs 19 ± 2 bpm). No statistically significant differences were observed in MAP time domain variability (Figure 2 ).
Baroreflex
The upper panels in Figure 3 show the MAP against HR baroreflex curve, along with the mean sigmoidal fitting, for SIO ( Figure 3A ) and TIO ( Figure 3B ) rats and their respective controls. The baroreflex gain coefficient versus pressure plot is reported in the lower panels in Figure 3 for both SIO ( Figure 3C ) and TIO ( Figure 3D ) animals.
The baroreflex curve for the TIO group was shifted to the left ( Figure 3B,D) , closely following the changes in resting MAP ( Figure  1) , as indicated by the MAP 50 value. No significant changes were observed in the baroreflex curve of SIO rats compared to control ( Figure 3A,C) . Maximal reflex tachycardia (upper plateau) and bradycardia (lower plateau), and consequently HR range, for the two iron-treated groups did not differ statistically from control (Table 2) . However, a tendency to a reduction in both upper plateau and HR range was noted in SIO rats when compared to sham rats (Table 2, Figure 3A) .
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Effects of acute deferoximine treatment
The upper panel in Figure 4 represents the gain coefficient of the baroreflex tachy-cardia (Equation 2) for the TIO and sham rats. The MAP range in which the baroreflex gain coefficient was evaluated corresponds to the linear portion of the baroreflex curve ( Figure 4 , lower panel; copied from Figure  3B indicating the MAP range).
Infusion of the free iron chelator (DFO) reduced the baroreflex gain values of the TIO rats (Table 3) to control levels (5.28 ± 0.86 vs 3.57 ± 0.27 bpm/mmHg) but did not affect the baroreflex gain coefficient in sham animals (3.77 ± 0.40 vs 3.66 ± 0.41 bpm/ mmHg) when baroreflex was evaluated by sodium nitroprusside injection.
Discussion
In this study, we sought to determine whether iron overload produced by intraperitoneal injections of iron dextran affects baroreflex function in conscious rats. The iron profile of SIO and TIO rats confirmed our expectation ( Table 1 ) of an experimental model that would compare the effect of high serum iron levels with the long-term effects of iron accumulated in tissue. The results demonstrated that the baroreflex gain was increased in TIO rats (Figure 3 ), whereas no differences in baroreflex function were observed in SIO rats. Furthermore, the data indicate a direct effect of iron in tissue, since DFO, a chelator, was able to reverse the phenomenon ( Figure 4) . Therefore, the present data support the view that iron overload plays a role in the functional changes regarding the effector components of baroreflex function, as suggested previously by others (22) . Figure 3B with the marked area showing the linear region of the baroreflex curve in which baroreflex was tested in the deferoxamine experiment. *P < 0.05 compared to the sham group; **P < 0.05 compared to the TIO rats before deferoxamine infusion (Student t-test). Table 3 . Changes in heart rate, mean arterial pressure and mean gain values of baroreflex evaluated by sodium nitroprusside before and after deferoxamine (20 mg/kg) infusion in sham and tissue iron overload rats.
Group
Before DFO After DFO Chronic iron overload produces heart dysfunction in a dose-dependent manner (8), probably resulting from the time lag necessary to deposit iron in tissues. In the heart, iron, initially deposited in the epicardium, has a long term-effect on transmural wall thickness (23, 24) . Such long-term effects do not seem to have occurred in TIO rats since DFO was able to acutely reverse the effect of iron overload on the baroreflex gain coefficient. The interpretation of the short-term and long-term effects of iron in the present study is compromised by the lack of published information concerning acceptable levels of iron in the rat. Neither the borderline levels of iron nor the exposure time needed in order to produce iron-related dysfunctions in the cardiovascular system have been reported. Nevertheless, several reports have demonstrated the possible role of cardiac iron deposition in the development of cardiomyopathy and heart failure within the iron overload paradigm (23, 25) .
On the basis of the Haber-Weiss and Fenton reactions, iron can produce hydroxyl radicals that might lead to oxidative stress. Extensive reviews about the effect of iron, even at low concentrations, on free radicals and calcium homeostasis are available (26) (27) (28) (29) . A dose-dependent effect of oxidative damage in rats submitted to the iron overload paradigm (30) agrees with our findings of the stronger cardiovascular effects encountered in TIO rats. Since deferoxamine chelates iron ions and limits the Haber-Weiss and Fenton reactions, preventing the formation of hydroxyl radicals, it becomes impossible to dissociate a direct effect of iron on cardiac tissue from that of free radicals. Thus, further studies using specific free radical scavengers should be carried out to elucidate the mechanism by which DFO was able to reverse the effect of the TIO protocol on the baroreflex gain coefficient.
Factors that modulate calcium homeostasis in cardiomyocytes affect both contractility and cardiac rhythm. The proper control of calcium inward current in myocytes is essential for normal electrical rhythms, while its dysfunction may generate life-threatening heart arrhythmias (31) along with other pathological conditions. Both ferrous ions (Fe 2+ ) and free radicals have been associated with the impairment and breakdown of Ca 2+ -ATPase proteins in the sarcoplasmic reticulum of the rat heart (26) . Oxidative stress has been suggested to enhance calcium currents through neuronal Ca 2+ channels (27) . The heart has a high density of L-type Ca 2+ channels, which are directly modulated by Fe 2+ ions (28) . In addition, myocardial Fe 2+ uptake has been reported to occur via L-type Ca 2+ channels (29) , indicating a complex interaction between calcium, iron and free radical generation in the heart and neuronal tissue. In synthesis, both excess of iron and free radicals have been implicated in the disruption of intracellular calcium homeostasis (32,33) not only in cardiomyocytes but also in neurons (34, 35) . Taken together, these reports agree with the hypothesis that the increase in baroreflex tachycardia (Figure 3 ) could represent an adjustment process to compensate for iron-induced failure in myocardial function, sustaining, at least in part, blood pressure within normal levels. In fact, the narrowing of the baroreflex curve, the increase in baroreflex gain coefficient and the left shift of the MAP 50 ( Figure 3B and D) suggest myocardial rather than neural dysfunction. In addition, our data from the baroreflex curve profiles of TIO rats very much resemble data reported by Meyrelles and collaborators (18) using an animal model of heart failure induced by occlusion of the anterior descending coronary artery. In their study, these investigators found that although the baroreflex gain coefficient was unaltered after the first day of infarction, 30 days after occlusion the baroreflex gain was significantly exaggerated. Still regarding the abovementioned report, one cannot fail to notice the striking similarities between the baroreflex curves and gain curves presented here (for the SIO and TIO protocols; Figure 3 ) and those of 1-and 30-day infarcted animals (18) . Nevertheless, the effects of iron overload on other factors that modulate calcium homeostasis in cardiomyocytes cannot be ruled out, such as Ca 2+ -ATPase pump involvement, low levels of Ca 2+ in the reticular sarcoplasm, Ca 2+ voltage-dependent channel sensitivity, or ryanodine receptor expression, among others (36, 37) .
Our results support the idea of a peripheral action of iron affecting baroreflex function, e.g., an iron-dependent impairment of myocardial function associated with heart failure, since DFO was able to reverse the effects of altered baroreflex gain observed in Figure 3 . Bartfay and collaborators (6) reported finding a decrease of baseline HR using the Langendorff isolated heart perfusion technique in iron dextran-treated mice. Our in vivo findings and Bartfay's ex vivo findings for baseline HR could be due to the same intrinsic mechanisms and could result, at least in part, from impairment of calcium channels due to the action of free radicals or to a direct action of ferrous iron. The decrease in pulse pressure observed in TIO rats can be interpreted as a possible consequence of the reduction of heart strength by ironinduced heart failure.
Our results support the hypothesis of ironinduced heart failure as an important factor for the development of the observed adjustment in baroreflex function. The data also indicate that the iron overload model is an interesting in vivo model for heart failure that is both gradual and, to some extent, reversible. Although we do not exclude the possibility of an involvement of free radicals and/or iron in the adjustments of the afferent baroreflex pathway, the data strongly indicate that the baroreflex curve change is the neural response to myocardial incapacity to properly respond to central control.
